McCamish Mark Anthony

McCamish Mark Anthony is listed in filings as Director at Avadel Pharmaceuticals plc. This profile follows SEC Form 4 activity through Feb 12, 2026, including 14 public disclosures. Recent filings connect the profile to Avadel Pharmaceuticals plc (AVDL). The current snapshot covers public activity from Aug 1, 2024 to Feb 12, 2026. Reported amounts are shown as $1.4M to $356.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.